Extremophiles are Revolutionizing Biotechnology

Breakthroughs in CRISPR genome editing technology have completely transformed how scientists both engineer and study extremophiles. These advancements allow researchers to identify the genes associated with extremotolerance and to potentially edit strains for industrial use. Furthermore, the application of CRISPR technology to different extremophile types may allow for the future development of various extremophilic cells for synthetic biology applications.


Image 1: A tardigrade in moss from Science Photo Library

Extremophiles are microorganisms that can survive in harsh environments that were previously thought to be uninhabitable. By living in high heat, intense cold, dryness, high salinity, alkaline, pressurized, heavy metal, and radiation environments, these organisms have developed unique genetic and metabolic adaptations that enable their survival. The resilience of extremophiles makes them highly valuable in biotechnology, including the production of thermostable DNA polymerase, as well as in industrial processes such as biofuel production, and environmental applications like bioremediation. With advances in CRISPR-Cas, a genome editing technology that utilizes Cas enzymes to delete, add, or replace genetic material in living cells, it is possible to enhance or manipulate extremophilic genomes, allowing scientists to uncover the genes responsible for extremotolerance.

By using CRISPR in thermophiles, a heat-tolerant extremophile, scientists have developed a thermostable Cas variant. This can be used to revolutionize high-temperature industrial biotechnology and to innovate bioremediation in geothermal environments. Another example of CRISPR use includes its application to psychrophiles, a cold-tolerant extremophile, to expand the use of psychrophiles for cold-chain bioprocessing, enzyme production, or bioremediation in polar or deep-sea ecosystems.

Given the vast array of extremophiles, the future potential for genome editing technologies in extremophiles is very promising. As CRISPR technology advances, research into the genetic basis of extremotolerance can be conducted with more precision. Furthermore, the engineering of strains with enhanced production of industrial enzymes, biofuels, bioplastics, or even metal recovery efficiency under extreme conditions can be developed. Developments can also improve the effectiveness of bioremediation in harsh environments. The continued investment in developing these frameworks is crucial to the future potential of new applications and biotechnologies.



Source:

https://www.sciencedirect.com/science/article/pii/S305064172500029


Additional:

https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2026.1754802/full

Cloning Your Pet?

    

    Numerous celebrities have cloned their deceased pets with biotechnology companies. For $50,000, these companies will insert the DNA of the desired animal into donor egg cells and create a genetically identical pet. As we know, a genome only accounts for a fraction of what makes an individual, along with the environment and other outside factors. While these companies promise a genetic twin, the pet will not be a true clone with potential differences in temperament and personality. By employing genetic engineering, the biotech company Collasal Biosciences, which has termed itself a ‘de-extinction’ company, has concentrated its efforts on diversifying the gene pool of endangered species in the hopes of bringing species out of extinction. 

Cloning pets maintains a degree of controversy including ethical and social concerns. There are a variety of businesses that capitalize off of the technique, including Viagen, which has claimed to clone more animals than any other company. However, concentrating the technology into preserving endangered species provides a novel approach to conserving a range of ecosystems. While cloning is trivial, different applications provide the opportunity for growth, preservation, and maintenance of our environment. The article raises relevant questions about the implications of cloning genes in society and what it means for the future of genetic engineering. 

Source: https://www.technologyreview.com/2025/11/07/1127692/cloning-celebrity-pets-tom-brady-dog-conservation/

Additional Link:

https://viagenpets.com/dog-cloning/?gad_source=1&gad_campaignid=23100856057

The Ethical Dilemma of Genetic Engineering: How Far Should We Go?

Genetic engineering is one of the most exciting and controversial topics in science today. Technologies like CRISPR allow scientists to edit genes, and this could mean huge breakthroughs in curing diseases or improving crops. But there's a big question: how far is too far when it comes to changing the genetic makeup of living things, especially humans? For example, gene editing could potentially lead to the creation of “designer babies” where parents pick traits like eye color or intelligence for their child. While that might sound cool, it also raises serious ethical issues. Scientific American discusses how scientists are trying to set guidelines to make sure gene editing is used responsibly and doesn’t go too far.


At the same time, gene editing could be a game-changer for treating genetic diseases. Imagine being able to fix a disease like sickle cell anemia by editing out the defective gene. This could change the lives of millions of people. But as exciting as this is, it also brings up tough questions. If we can cure diseases, should we also be allowed to enhance people’s genes for things like better athletic ability or intelligence? The NCBI article dives into these tough ethical issues, pointing out that while gene editing has huge potential, we need to be careful and think about the bigger picture.